001     277881
005     20250427001148.0
024 7 _ |a 10.1038/s44320-025-00093-6
|2 doi
024 7 _ |a pmid:40133533
|2 pmid
024 7 _ |a pmc:PMC11965535
|2 pmc
024 7 _ |a altmetric:175461358
|2 altmetric
037 _ _ |a DZNE-2025-00501
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Simonis, Alexander
|0 0000-0003-2945-9897
|b 0
245 _ _ |a Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages.
260 _ _ |a [London]
|c 2025
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1745404276_31858
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Immune memory plays a critical role in the development of durable antimicrobial immune responses. How precisely mRNA vaccines train innate immune cells to shape protective host defense mechanisms remains unknown. Here we show that SARS-CoV-2 mRNA vaccination significantly establishes histone H3 lysine 27 acetylation (H3K27ac) at promoters of human monocyte-derived macrophages, suggesting epigenetic memory. However, we found that two consecutive vaccinations were required for the persistence of H3K27ac, which matched with pro-inflammatory innate immune-associated transcriptional changes and antigen-mediated cytokine secretion. H3K27ac at promoter regions were preserved for six months and a single mRNA booster vaccine potently restored their levels and release of macrophage-derived cytokines. Interestingly, we found that H3K27ac at promoters is enriched for G-quadruplex DNA secondary structure-forming sequences in macrophage-derived nucleosome-depleted regions, linking epigenetic memory to nucleic acid structure. Collectively, these findings reveal that mRNA vaccines induce a highly dynamic and persistent training of innate immune cells enabling a sustained pro-inflammatory immune response.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Epigenetic Memory
|2 Other
650 _ 7 |a G-quadruplex
|2 Other
650 _ 7 |a H3K27ac
|2 Other
650 _ 7 |a SARS-Cov-2 mRNA Vaccination
|2 Other
650 _ 7 |a Trained Innate Immunity
|2 Other
650 _ 7 |a Histones
|2 NLM Chemicals
650 _ 7 |a COVID-19 Vaccines
|2 NLM Chemicals
650 _ 7 |a Cytokines
|2 NLM Chemicals
650 _ 7 |a RNA, Messenger
|2 NLM Chemicals
650 _ 7 |a mRNA Vaccines
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Macrophages: immunology
|2 MeSH
650 _ 2 |a Macrophages: metabolism
|2 MeSH
650 _ 2 |a Epigenesis, Genetic
|2 MeSH
650 _ 2 |a SARS-CoV-2: immunology
|2 MeSH
650 _ 2 |a SARS-CoV-2: genetics
|2 MeSH
650 _ 2 |a COVID-19: immunology
|2 MeSH
650 _ 2 |a COVID-19: prevention & control
|2 MeSH
650 _ 2 |a Histones: metabolism
|2 MeSH
650 _ 2 |a Histones: immunology
|2 MeSH
650 _ 2 |a Histones: genetics
|2 MeSH
650 _ 2 |a Immunologic Memory
|2 MeSH
650 _ 2 |a Promoter Regions, Genetic
|2 MeSH
650 _ 2 |a Acetylation
|2 MeSH
650 _ 2 |a COVID-19 Vaccines: immunology
|2 MeSH
650 _ 2 |a Immunity, Innate
|2 MeSH
650 _ 2 |a Cytokines: metabolism
|2 MeSH
650 _ 2 |a Vaccination
|2 MeSH
650 _ 2 |a RNA, Messenger: immunology
|2 MeSH
650 _ 2 |a mRNA Vaccines: immunology
|2 MeSH
650 _ 2 |a Epigenetic Memory
|2 MeSH
693 _ _ |0 EXP:(DE-2719)PRECISE-20190321
|5 EXP:(DE-2719)PRECISE-20190321
|e Platform for Single Cell Genomics and Epigenomics at DZNE University of Bonn
|x 0
700 1 _ |a Theobald, Sebastian J
|b 1
700 1 _ |a Koch, Anna E
|0 0009-0003-1593-9715
|b 2
700 1 _ |a Mummadavarapu, Ram
|0 0009-0009-4244-8982
|b 3
700 1 _ |a Mudler, Julie M
|0 0000-0003-1378-9648
|b 4
700 1 _ |a Pouikli, Andromachi
|b 5
700 1 _ |a Göbel, Ulrike
|b 6
700 1 _ |a Acton, Richard
|0 0000-0002-2574-9611
|b 7
700 1 _ |a Winter, Sandra
|b 8
700 1 _ |a Albus, Alexandra
|b 9
700 1 _ |a Holzmann, Dmitriy
|b 10
700 1 _ |a Albert, Marie-Christine
|b 11
700 1 _ |a Hallek, Michael
|b 12
700 1 _ |a Walczak, Henning
|0 0000-0002-6312-4591
|b 13
700 1 _ |a Ulas, Thomas
|0 P:(DE-2719)9000845
|b 14
|u dzne
700 1 _ |a Koch, Manuel
|0 0000-0002-2962-7814
|b 15
700 1 _ |a Tessarz, Peter
|0 0000-0002-6953-9835
|b 16
700 1 _ |a Hänsel-Hertsch, Robert
|0 0000-0002-2835-4471
|b 17
700 1 _ |a Rybniker, Jan
|0 0000-0001-8351-2690
|b 18
773 _ _ |a 10.1038/s44320-025-00093-6
|g Vol. 21, no. 4, p. 341 - 360
|0 PERI:(DE-600)2193510-5
|n 4
|p 341 - 360
|t Molecular systems biology
|v 21
|y 2025
|x 1744-4292
856 4 _ |u https://pub.dzne.de/record/277881/files/DZNE-2025-00501%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/277881/files/DZNE-2025-00501.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/277881/files/DZNE-2025-00501.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:277881
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)9000845
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 1
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL SYST BIOL : 2022
|d 2025-01-07
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-02-27T14:26:31Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-02-27T14:26:31Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-07
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-07
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOL SYST BIOL : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1013038
|k AG Schultze
|l Clinical Single Cell Omics (CSCO) / Systems Medicine
|x 0
920 1 _ |0 I:(DE-2719)1013031
|k PRECISE
|l Platform for Single Cell Genomics and Epigenomics
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013038
980 _ _ |a I:(DE-2719)1013031
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21